IL159863A0 - Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents - Google Patents
Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agentsInfo
- Publication number
- IL159863A0 IL159863A0 IL15986302A IL15986302A IL159863A0 IL 159863 A0 IL159863 A0 IL 159863A0 IL 15986302 A IL15986302 A IL 15986302A IL 15986302 A IL15986302 A IL 15986302A IL 159863 A0 IL159863 A0 IL 159863A0
- Authority
- IL
- Israel
- Prior art keywords
- acylsemicarbazides
- cancer
- kinase inhibitors
- dependent kinase
- cyclin dependent
- Prior art date
Links
- 230000001093 anti-cancer Effects 0.000 title 1
- 230000001028 anti-proliverative effect Effects 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000002875 cyclin dependent kinase inhibitor Substances 0.000 title 1
- 229940043378 cyclin-dependent kinase inhibitor Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/906,963 US6593356B2 (en) | 1999-10-20 | 2001-07-16 | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| PCT/US2002/022663 WO2003007883A2 (en) | 2001-07-16 | 2002-07-16 | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL159863A0 true IL159863A0 (en) | 2004-06-20 |
Family
ID=25423309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15986302A IL159863A0 (en) | 2001-07-16 | 2002-07-16 | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6593356B2 (xx) |
| EP (1) | EP1417177A4 (xx) |
| JP (1) | JP2004536853A (xx) |
| KR (1) | KR20040015368A (xx) |
| CN (1) | CN1553900A (xx) |
| BR (1) | BR0211203A (xx) |
| CA (1) | CA2453594A1 (xx) |
| HU (1) | HUP0401588A3 (xx) |
| IL (1) | IL159863A0 (xx) |
| MX (1) | MXPA04000531A (xx) |
| NO (1) | NO20040175L (xx) |
| PL (1) | PL366912A1 (xx) |
| RU (1) | RU2004104329A (xx) |
| WO (1) | WO2003007883A2 (xx) |
| ZA (1) | ZA200400332B (xx) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040048844A1 (en) * | 1999-10-20 | 2004-03-11 | Bristol-Myers Squibb Pharma Company | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| JP3821090B2 (ja) * | 2002-10-22 | 2006-09-13 | トヨタ自動車株式会社 | 内燃機関の始動制御装置 |
| US7456169B2 (en) | 2003-02-27 | 2008-11-25 | Abbott Laboratories Inc. | Heterocyclic kinase inhibitors |
| US7320986B2 (en) | 2003-03-07 | 2008-01-22 | Abbott Labortories | Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| JP5136929B2 (ja) | 2004-03-24 | 2013-02-06 | アボット・ラボラトリーズ | 三環式ピラゾール系キナーゼ阻害薬 |
| US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
| US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
| US20100198034A1 (en) | 2009-02-03 | 2010-08-05 | Abbott Diabetes Care Inc. | Compact On-Body Physiological Monitoring Devices and Methods Thereof |
| EP3001194B1 (en) | 2009-08-31 | 2019-04-17 | Abbott Diabetes Care, Inc. | Medical devices and methods |
| ES2881798T3 (es) | 2010-03-24 | 2021-11-30 | Abbott Diabetes Care Inc | Insertadores de dispositivos médicos y procedimientos de inserción y uso de dispositivos médicos |
| FI3300658T3 (fi) | 2011-12-11 | 2024-03-01 | Abbott Diabetes Care Inc | Analyyttianturimenetelmiä |
| US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
| EA201891170A1 (ru) | 2015-11-18 | 2018-11-30 | Джензим Корпорейшн | Биомаркер поликистозной болезни почек и варианты его применения |
| GB201721185D0 (en) | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
| WO2020249667A1 (en) | 2019-06-12 | 2020-12-17 | NodThera Limited | Sulfonylurea derivatives and uses thereof |
| USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9909597A (pt) * | 1998-04-21 | 2001-10-02 | Du Pont Pharm Co | Composto, composição farmacêutica e método de tratamento de câncer e doenças proliferativas |
| US6407103B2 (en) * | 1998-04-21 | 2002-06-18 | Bristol-Myers Squibb Pharma Company | Indeno [1,2-c] pyrazol-4-ones and their uses |
| US6291504B1 (en) * | 1999-10-20 | 2001-09-18 | Dupont Pharmaceuticals Company | Acylsemicarbazides and their uses |
| EP1414804A1 (en) * | 2000-10-20 | 2004-05-06 | Bristol-Myers Squibb Pharma Company | Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| WO2002044174A2 (en) * | 2000-12-01 | 2002-06-06 | Bristol-Myers Squibb Pharma Company | 3-(2,4-dimethylthiazol-5-yl) indeno[1,2-c]pyrazol-4-one derivatives as cdk inhibitors |
-
2001
- 2001-07-16 US US09/906,963 patent/US6593356B2/en not_active Expired - Lifetime
-
2002
- 2002-07-16 BR BR0211203-5A patent/BR0211203A/pt not_active IP Right Cessation
- 2002-07-16 CA CA002453594A patent/CA2453594A1/en not_active Abandoned
- 2002-07-16 RU RU2004104329/04A patent/RU2004104329A/ru not_active Application Discontinuation
- 2002-07-16 KR KR10-2004-7000762A patent/KR20040015368A/ko not_active Application Discontinuation
- 2002-07-16 IL IL15986302A patent/IL159863A0/xx unknown
- 2002-07-16 EP EP02748186A patent/EP1417177A4/en not_active Withdrawn
- 2002-07-16 HU HU0401588A patent/HUP0401588A3/hu unknown
- 2002-07-16 WO PCT/US2002/022663 patent/WO2003007883A2/en active Application Filing
- 2002-07-16 JP JP2003513492A patent/JP2004536853A/ja not_active Abandoned
- 2002-07-16 CN CNA028177614A patent/CN1553900A/zh active Pending
- 2002-07-16 MX MXPA04000531A patent/MXPA04000531A/es unknown
- 2002-07-16 PL PL02366912A patent/PL366912A1/xx not_active Application Discontinuation
-
2004
- 2004-01-15 ZA ZA2004/00332A patent/ZA200400332B/en unknown
- 2004-01-15 NO NO20040175A patent/NO20040175L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004536853A (ja) | 2004-12-09 |
| US6593356B2 (en) | 2003-07-15 |
| WO2003007883A3 (en) | 2003-05-22 |
| HUP0401588A2 (hu) | 2005-01-28 |
| EP1417177A4 (en) | 2005-10-19 |
| KR20040015368A (ko) | 2004-02-18 |
| EP1417177A2 (en) | 2004-05-12 |
| RU2004104329A (ru) | 2005-07-10 |
| US20030073686A1 (en) | 2003-04-17 |
| BR0211203A (pt) | 2004-09-28 |
| CN1553900A (zh) | 2004-12-08 |
| CA2453594A1 (en) | 2003-01-30 |
| PL366912A1 (en) | 2005-02-07 |
| WO2003007883A2 (en) | 2003-01-30 |
| NO20040175L (no) | 2004-03-12 |
| MXPA04000531A (es) | 2004-05-04 |
| HUP0401588A3 (en) | 2005-06-28 |
| ZA200400332B (en) | 2005-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1064360A1 (en) | Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents | |
| AU2002362895A1 (en) | 5-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors | |
| MXPA03006420A (es) | Diaminotiazoles. | |
| HK1066546A1 (en) | Trifluoromethylpurines as phosphodiesterase 4 inhibitors | |
| SI1583542T1 (sl) | Sestavki in postopki za kombinacijsko antivirusnoterapijo | |
| IL161516A0 (en) | Benzimidazoles useful as protein kinase inhibitors | |
| AU2002357119A8 (en) | Mitocidal compositions and methods | |
| PL366038A1 (en) | Nucleoside compounds and uses thereof | |
| EP1423120A4 (en) | 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF | |
| HK1061854A1 (en) | Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
| IL159863A0 (en) | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents | |
| PL372620A1 (en) | New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors | |
| PL363391A1 (en) | Phthalayinone-piperidino-derivatives as pde4 inhibitors | |
| EP1469860A4 (en) | ANTICANCER COMBINATION AND USE THEREOF | |
| AU2002357748A8 (en) | Osteopontin-related compositions and methods | |
| GB2376928B (en) | Personal hoverplane having four tiltmotors | |
| GB0101686D0 (en) | Cyclin dependent kinase inhibitors | |
| EP1583528A4 (en) | NF-KB INHIBITORS AND ITS USES | |
| EP1694640A4 (en) | ANTI CANCER AGENTS | |
| EP1631145A4 (en) | P38 KINASEHEMMER COMPOSITION AND METHOD FOR THEIR USE | |
| EP1507542A4 (en) | ANTICANCER PREPARATION | |
| EP1501923A4 (en) | COMPOSITIONS AND METHODS RELATING TO PAK5 | |
| GB0230292D0 (en) | Anti-cancer agents | |
| AU2002351768A1 (en) | Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors | |
| GB2369445B (en) | Component measures |